What Xiros does

Xiros is a UK-headquartered, privately held medical device company founded in 1982 in Leeds that designs, develops, manufactures, and markets sterile implantable devices for sports medicine and orthopaedic surgery. Its product portfolio centres on synthetic polyester-based implants — including JewelACL for anterior cruciate ligament reconstruction, Pitch-Patch for massive rotator cuff reinforcement, the Infinity-Lock family for MPFL reconstruction and acromioclavicular joint repair, AchilloCordPLUS for Achilles tendon repair, the FlexPasser tendon retrieval kit, and a range of Poly-Tape systems for tissue approximation — built around an open-weave, multifilament polyethylene terephthalate architecture that the company reports enables tissue integration while providing immediate mechanical strength. Several products were co-developed with named surgeon key opinion leaders (e.g., Dr. Jan Leuzinger for Pitch-Patch, Mr. Danny Acton for MPFL techniques), and the company maintains a body of peer-reviewed clinical evidence supporting outcomes such as reduced rotator cuff retear rates and long-term ACL reconstruction durability.

Xiros generates revenue through B2B sales of sterile single-use implants and instruments to hospitals, surgical centres, and surgeons, distributed internationally via a network of authorised distributors and, in North America, through its wholly owned subsidiary Xiros North America (xirosna.com). Pricing is quote-based and not publicly disclosed; contracts can run on multi-year terms per the company's Terms of Sale. The go-to-market motion is sales-led and grounded in medical education: the Xiros Training Academy runs cadaveric and instructional courses (notably in Amsterdam), the company participates actively in major orthopaedic congresses (ESSKA, AAOS, ISAKOS, EFORT, among others), and a clinical-evidence-heavy content strategy (peer-reviewed papers, case reports, white papers, surgeon and patient testimonials) supports adoption. In July 2023 the company consolidated its former Neoligaments and Xiros Surgical brands under the unified Xiros parent name to reduce customer complexity and support expansion into new global markets; the company is led by Chairman Dr Bahaa Seedhom and operates without disclosed external private equity or venture capital backing.

Name

Xiros

Legal name

Xiros Limited

Website

https://xiros.co.uk

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

101–250 employees

Short description

Xiros, founded in 1982 and headquartered in Leeds, UK, designs and manufactures sterile synthetic implantable medical devices — including JewelACL, Pitch-Patch, and Infinity-Lock systems — for orthopaedic and sports medicine surgeons, selling globally through distributor networks and a North American subsidiary.

Ownership category

akta.pro rank

Product category

Orthopaedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Orthopaedic medical devices
• Sports medicine implants
• Ligament reconstruction
• Synthetic surgical grafts
• Tendon repair devices

Headquarters

HQ city

Leeds

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Xiros designs, develops, manufactures, and markets innovative sterile implantable medical devices for sports medicine and orthopaedic markets. Revenue is generated through the sale of surgical implants (JewelACL, Pitch-Patch, Infinity-Lock systems, Poly-Tapes, AchilloCordPLUS, FlexPasser) and instruments to healthcare facilities and surgeons through distributor networks.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Xiros designs, develops, manufactures, and markets sterile implantable medical devices for orthopaedic and sports medicine surgery. Its product range centres on synthetic (polyester / polyethylene terephthalate) grafts, tapes, buttons, and instruments used for ligament, tendon and soft-tissue reconstruction across the shoulder, knee, hand/wrist/elbow, and foot/ankle. Products are sold to healthcare professionals and facilities through authorised distributors and a direct North American sales operation.

Product overview

Xiros offers a portfolio of sterile implantable medical devices for sports medicine and orthopaedic surgery. The product line centers on synthetic implants for ligament, tendon, and soft tissue reconstruction across multiple anatomical areas: shoulder (Pitch-Patch rotator cuff reinforcement, Infinity-Lock Button System for AC joint separation), knee (JewelACL for ACL reconstruction, Infinity-Lock Tape for MPFL and MCL reconstruction, Poly-Tape for patellar/quadriceps tendon repair), hand (FlexPasser Tendon Retrieval Kit), and foot/ankle (AchilloCordPLUS for Achilles tendon repair). The products use synthetic materials like polyester fabric and feature designs that allow tissue integration. The company formerly operated as Neoligaments and Xiros Surgical before rebranding under the single Xiros name in 2023.

Differentiator

Problem solved

Functional benefit

Products and services

• Pitch-Patch Single-use implantable device constructed from warp knitted polyethylene terephthalate (polyester) fabric with integral eyelets, indicated for reinforcement of rotator cuff repairs where tear cannot be completely repaired or tissue quality is poor; can be used in arthroscopic or open techniques with very high average strength (>400 N) when fully sutured along the medial edge.
• Infinity-Lock Button System Surgical solution for acromioclavicular joint separation repair that uses Infinity-Lock Tape together with a low-profile titanium button to re-align the collarbone to the shoulder blade, reducing pain and improving appearance.
• JewelACL Polyester permanent implant for anterior cruciate ligament reconstruction with matching strength to natural ACL (~1200 N), featuring a tubular, flexible, open weave structure made from multifilament yarns, usable alone or with hamstring graft.
• Infinity-Lock Tape High-strength, low-profile synthetic tape for medial patellofemoral ligament (MPFL) reconstruction to address patellar instability; also used for elbow stabilisation and other ligament reconstruction procedures.
• Poly-Tape (LK-2 Polyester Fabric) Open weave structure implants made from woven multifilament high-tenacity polyester (polyethylene terephthalate) fibre, supplied in various sizes and configurations for tissue approximation and reconstruction of damaged or torn ligaments, tendons, and soft tissues.
• FlexPasser Tendon Retrieval Kit Single-use instrumentation kit enabling atraumatic retrieval of retracted proximal flexor tendon stumps through minimal incisions during repair of lacerated digital flexor tendons in the hand, wrist and elbow.
• AchilloCordPLUS System Densely woven flexible tubular synthetic structure for acute Achilles tendon repair, particularly suited to patients where extended post-operative immobilisation is undesirable, enabling early rehabilitation and partial weight bearing.
• PatellarTape System Procedure-specific system for patellar tendon reconstruction built on Xiros Poly-Tape technology; available in the UK and Australia.
• QuadsTape System Procedure-specific system for quadriceps tendon reconstruction built on Xiros Poly-Tape technology; available in the UK and Australia.

Quantifiable outcome

• Re-tear rate reduction from 42-79% (expected) to 14% in massive rotator cuff tears with Pitch-Patch augmentation (JSES 2019 study)
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Show + TellminorOthersYorkshire-based branding agency that delivered the Xiros rebrand project, consolidating Neoligaments and Xiros Surgical under the unified Xiros brand. Also responsible for WordPress website design and build.
• Dr. Med. Jan LeuzingercoreStrategic or Co-development Partneretzelclinic, Pfäffikon, Switzerland - Co-developed the Pitch-Patch rotator cuff reinforcement device with first implantations in 2012. Continues to provide surgeon education and webinars on Pitch-Patch techniques.
• Xiros Distributor NetworkcoreChannel Partner/ Reseller/ DistributorGlobal network of authorised distributors for Xiros medical devices. Includes regional distributors for Australia and other international markets as indicated on website.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Arthrex: Global leader in arthroscopic and orthopedic sports medicine implants and instruments. Direct competitor across shoulder, knee, and soft-tissue reconstruction, but at vastly greater scale and product breadth than Xiros.
• Smith & Nephew: Major orthopedic medical device company with a dedicated Sports Medicine franchise (including ACL, rotator cuff, and shoulder repair products). Comparable to Xiros in target procedures but much broader portfolio and global reach.
• Stryker: Large diversified orthopedic player with sports medicine offerings spanning shoulder, knee, and extremities. Comparable end-user call point (orthopedic surgeons) but far larger indication breadth.
• DePuy Synthes Mitek Sports Medicine: Johnson & Johnson's sports medicine division selling ACL reconstruction, rotator cuff, and shoulder implants. Direct head-to-head competitor to Xiros on synthetic ligament reconstruction and soft-tissue fixation.
• Zimmer Biomet: Global orthopedic and sports medicine device manufacturer with significant ligament and soft-tissue reconstruction offerings. Overlaps with Xiros in surgeon call points but with much larger indication and product range.

Direct peers

• ConMed Linvatec: Dedicated sports medicine and orthopedic implant manufacturer offering products in arthroscopy, ACL, and shoulder reconstruction. Mid-size player more closely aligned with Xiros' specialty focus than the largest incumbents.
• Integra LifeSciences: Specialty medical device company with orthopedics and tissue technologies franchises, including regenerative and reconstructive implant products. Comparable mid-size specialty competitor in soft-tissue orthopedic reconstruction.

Emerging players

• LifeNet Health: Non-profit tissue bank offering allograft and biologic solutions for orthopedic and sports medicine reconstruction. Competes with Xiros in ligament and tendon repair but via biologic grafts rather than synthetic implants.
• MedShape: Niche orthopedic device company developing shape-memory and novel-fixation implants for foot/ankle and other extremities. Comparable specialty medical device profile with focused implant portfolio.

Regional players

• Karl Storz (Sports Medicine division): Stronger in endoscopy and visualization but with growing sports medicine/arthroscopy implants and instruments in Europe. Competitor in surgical technique enablement alongside Xiros' implant portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/XirosLtd
• Facebookfacebook.com/sharer.php
• LinkedInlinkedin.com/company/xiros

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xiros